Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire30 March 2026RBC and HTS (Hopper Technology Solutions) Come Together to Elevate the Travel Booking Experience for Canadians
RBC taps HTS to power Avion Rewards Travel, bringing innovative travel offerings to the Canadian market; new travel booking portal to…
Read More » -
Cision PR Newswire30 March 2026National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2…
Read More » -
Cision PR Newswire30 March 2026Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions…
Read More » -
Cision PR Newswire30 March 2026National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2…
Read More » -
Cision PR Newswire30 March 2026IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG) induced accumulation of TOP1…
Read More » -
Cision PR Newswire30 March 2026Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions…
Read More » -
Cision PR Newswire30 March 2026IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG) induced accumulation of TOP1…
Read More » -
Cision PR Newswire30 March 2026Search Homes and See What You Can Afford with the New Realtor.com® App in ChatGPT
The app simplifies critical budget and location decisions for home shoppers, while also safeguarding MLS data AUSTIN, Texas, March 30,…
Read More » -
Cision PR Newswire30 March 2026Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions…
Read More » -
Cision PR Newswire30 March 2026From Experience to Trust: KuCoin Connects Crypto with Culture at Tomorrowland Winter
PROVIDENCIALES, Turks and Caicos Islands, March 30, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, concluded…
Read More »